ETEFVsCEF: Early Total Enteral Feeding Versus Convention Enteral Feeding in Preterm Infants 27-32 Weeks of Gestation

Sponsor
Lady Hardinge Medical College (Other)
Overall Status
Recruiting
CT.gov ID
NCT06076460
Collaborator
(none)
160
1
2
24
6.7

Study Details

Study Description

Brief Summary

The objective of the study is to compare the time of attainment of full enteral feeds in preterm neonates between 27-32 weeks of gestation started on early total enteral feeding (ETEF) with those started on conventional enteral feeding (CEF).

Condition or Disease Intervention/Treatment Phase
  • Other: Early Total Enteral Feeding
  • Other: Conventional Enteral Feeding
N/A

Detailed Description

Enrolled participants will be randomly assigned to one of two study groups: 1) early total enteral feeding (ETEF) or 2) conventional enteral feeding (CEF). Regardless of study group assignment, mother's own breast milk (MOM) is the feed of choice and donor human milk is being offered if the MOM is not enough to complete the intervention as assigned

Intervention group: Feeds will be initiated with a target volume of 80 ml/kg/day starting within the first two hours after birth. Volumes will increased by 20 ml/kg/day till day 4 (total 140 ml/kg/d) and then 150ml/kg/day on day 5.

Control group: This group will receive enteral feeding volumes at a rate of 20 ml/kg/day starting within the first two hours after birth and rest of the daily requirement as Total parenteral nutrition. Volumes will be increased by 20 ml/kg/day till day 3 and thereafter by 30 ml/kg/d till 150ml/kg/day on day 6.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
160 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Early Total Enteral Feeding Versus Convention Enteral Feeding in Preterm Neonates Between 27 to 32 Weeks of Gestation: A Randomized Control Trial
Actual Study Start Date :
Mar 11, 2022
Anticipated Primary Completion Date :
Jan 10, 2024
Anticipated Study Completion Date :
Mar 10, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Early Total Enteral Feeding

Mom's milk or donor milk at 80 ml/kg/day after randomization within the first 2 hours

Other: Early Total Enteral Feeding
This group will receive enteral feeding volumes at a rate of 80 ml/kg/day starting within the first two hours after birth. Volumes will increased by 20 ml/kg/day till day 4 (total 140 ml/kg/d) and then 150ml/kg/day on day 5.

Active Comparator: Conventional Enteral Feeding

Mom's milk or donor milk at 20 ml/kg/day and rest of the requirement as Total parenteral nutrition after randomization within the first 2 hours.

Other: Conventional Enteral Feeding
This group will receive enteral feeding volumes at a rate of 20 ml/kg/day starting within the first two hours after birth and rest of the daily requirement as Total parenteral nutrition. Volumes will be increased by 20 ml/kg/day till day 3 and thereafter by 30 ml/kg/d till 150ml/kg/day on day 6.

Outcome Measures

Primary Outcome Measures

  1. Time of attainment of full enteral feeds (150ml/kg/day) during the first 28 days after birth [Birth to 28 days]

    Days to attain full feeds during the first 28 days after birth

Secondary Outcome Measures

  1. Number of episodes of feeding intolerance [From Randomization till 28 days after birth]

    Feed intolerance will be defined as any one or more of the following a) Vomiting 3 or more in any 24 hour period, b) Any episode of blood stained or bilious vomiting, c) Abdominal girth(AG) increase >2 cm (with pre-feed aspirate >25%), abdominal wall erythema or tenderness, gross or occult blood in stools

  2. Incidence of Necrotising Enterocolitis [From Randomization till 28 days after birth]

    Diagnosis of necrotizing enterocolitis any stage

  3. Incidence of Sepsis [From randomization till 28 days after birth]

    Sepsis will be defined as any one of the following in a symptomatic neonate a) Culture positive sepsis b) Sepsis screen positive, c) Strong clinical suspicion such as sclerema, shock or clinical deterioration on supportive therapy which warrants initiation of antibiotics (clinician decision)

  4. Total duration of intravenous fluid usage [From randomization till 28 days after birth]

    Duration in completed days for which infant required parenteral fluid support

  5. Time of regaining birth weight [From randomization till 28 days after birth]

    Duration in completed days required to regain birth weight

  6. Total duration of hospital stay [From randomization till 2 months after birth]

    Duration in completed days required for treatment till discharge home or till death

  7. Weight gain per kg per day at 1 month of age [Birth to 30 days]

    The weight in grams at one month of age minus the birth weight divided by the average weight (average weight =birth weight +Weight at 1 month age divided by 2) further divided by 30

  8. Extrauterine growth retardation (EUGR) [Till 36 weeks Postmenstrual age]

    Weight of the infants at 36 weeks Postmenstrual age or at discharge (if earlier) below the 10th centile for age

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A to 1 Hour
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

Preterm neonate with gestational age of 27-32 weeks

Exclusion Criteria:
  1. Antenatally diagnosed GI malformation

  2. Baby born with absence or reversal of end diastolic flow on antenatal umbilical artery Doppler.

  3. Presence of major congenital anomalies at birth

  4. Need of vasopressor support at the time of randomization

  5. Requiring Positive Pressure Ventilation > 60 sec with APGAR score < 4 at 1 minute

Contacts and Locations

Locations

Site City State Country Postal Code
1 Lady Hardinge Medical College New Delhi Delhi India 110001

Sponsors and Collaborators

  • Lady Hardinge Medical College

Investigators

  • Study Chair: Sushma Nangia, DM (NEO), Lady Hardinge Medical College

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Sushma Nangia, M.D., Dr Sushma Nangia, Director Professor & Head, Neonatology, Lady Hardinge Medical College
ClinicalTrials.gov Identifier:
NCT06076460
Other Study ID Numbers:
  • LHMC/IEC/2021/03/68
First Posted:
Oct 10, 2023
Last Update Posted:
Oct 10, 2023
Last Verified:
Oct 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 10, 2023